Tredegar (TG) Q2 2025 earnings summary

Executive summary

• Net income from continuing operations was $1.8M ($0.05/share) in Q2 2025, down from $9.2M ($0.27/share) in Q2 2024; ongoing operations net income also declined to $1.8M from $10.3M year-over-year.

• Q2 2025 net sales were $179.1M, up from $153.9M in Q2 2024; Aluminum Extrusions sales volume rose 16.6%, while PE Films volume declined 7.1%.

• EBITDA from ongoing operations for Aluminum Extrusions was $9.3M (Q2 2025) vs. $12.9M (Q2 2024); for PE Films, $6.7M vs. $10.1M.

• Manufacturing inefficiencies in April and May 2025 impacted profitability but were resolved by quarter-end.

• Sale of Terphane (flexible packaging films business) completed in Q4 2024; historical results now presented as discontinued operations.

Financial highlights

• Q2 2025 consolidated net sales were $179.1M, up from $153.9M in Q2 2024; six-month sales were $343.9M, up from $297.9M year-over-year.

• Net income from ongoing operations for Q2 2025 was $1.8M, down from $10.3M in Q2 2024; six-month net income from continuing operations was $2.5M, down from $11.8M.

• Gross profit margin declined to 13.6% in Q2 2025 from 19.2% in Q2 2024.

• Operating cash flow was $(2.9)M for the first six months of 2025.

• Cash and cash equivalents at June 30, 2025 were $9.8M.

Outlook and guidance

• Management expects moderation in PE Films performance in the second half of 2025 after a strong first half.

• Capital expenditures projected at $17M for Aluminum Extrusions and $2M for PE Films in 2025.

• Management believes existing borrowing availability, cash balances, and cash flow from operations are sufficient for at least the next 12 months.

• Liquidity remains strong with $51M available under the $125M ABL facility as of June 30, 2025.

• No adverse impact on customer demand from tariffs yet, but situation remains fluid.